UK CHIEF medical officer Dame Sally Davies has announced she has reached the conclusion that there is evidence for therapeutic benefits of cannabis-based medicinal products for certain conditions.
As a result these products will be moved out of Schedule 1 of the Misuse of Drugs Regulations 2001 in England.
A further review by the Advisory Council on the Misuse of Drugs will potentially ratify the decision.
Davies summarised the recent evidence specifically for medicinal use of cannabis on prescription, and not recreational use, in a report which is part of a series of measures looking at the scheduling of cannabis, announced by the Home Secretary Sajid Javid 19 Jun.
"Moving these drugs out of Schedule 1 would allow them to be prescribed under controlled conditions by registered practitioners for medical benefit," Davies wrote.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Jul 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Jul 18
